124 related articles for article (PubMed ID: 35274748)
21. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
Kiely JR; Patel AJK
J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
[TBL] [Abstract][Full Text] [Related]
22. Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.
Manola I; Mataic A; Drvar DL; Pezelj I; Dzombeta TR; Kruslin B
In Vivo; 2020; 34(3):1271-1275. PubMed ID: 32354918
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
24. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.
Fröhlich E; Möhrle M; Klessen C
Arch Dermatol Res; 2004 Mar; 295(10):411-21. PubMed ID: 14767779
[TBL] [Abstract][Full Text] [Related]
25. Increased Marginal Stiffness Differentiates Infiltrative From Noninfiltrative Cutaneous Basal Cell Carcinomas in the Facial Area: A Prospective Study.
Alfageme F; Salgüero I; Nájera L; Suarez ML; Roustan G
J Ultrasound Med; 2019 Jul; 38(7):1841-1845. PubMed ID: 30467885
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
27. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.
Kaur P; Mulvaney M; Carlson JA
Am J Dermatopathol; 2006 Aug; 28(4):293-307. PubMed ID: 16871032
[TBL] [Abstract][Full Text] [Related]
28. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice.
Mancuso M; Pazzaglia S; Tanori M; Hahn H; Merola P; Rebessi S; Atkinson MJ; Di Majo V; Covelli V; Saran A
Cancer Res; 2004 Feb; 64(3):934-41. PubMed ID: 14871823
[TBL] [Abstract][Full Text] [Related]
29. Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma.
Swetter SM; Yaghmai D; Egbert BM
J Cutan Pathol; 1998 Sep; 25(8):420-5. PubMed ID: 9826167
[TBL] [Abstract][Full Text] [Related]
30. Pigmented basal cell carcinoma: investigation of 70 cases.
Maloney ME; Jones DB; Sexton FM
J Am Acad Dermatol; 1992 Jul; 27(1):74-8. PubMed ID: 1377719
[TBL] [Abstract][Full Text] [Related]
31. Basal cell carcinoma with thickened basement membrane: a variant that resembles some benign adnexal neoplasms.
El-Shabrawi L; LeBoit PE
Am J Dermatopathol; 1997 Dec; 19(6):568-74. PubMed ID: 9415612
[TBL] [Abstract][Full Text] [Related]
32. Comparison of PTCH1, COX-2, p53, and Ki-67 protein expression in basal cell carcinomas of nodular and superficial subtypes arising on the head and trunk.
Khalesi M; Waterhouse M; Whiteman DC; Johns R; Rosendahl C; Hackett T; Pollak T; Kimlin MG; Hacker E; Neale RE;
Int J Dermatol; 2016 Oct; 55(10):1096-105. PubMed ID: 27126210
[TBL] [Abstract][Full Text] [Related]
33. Immunoexpression of p53 and COX-2 in basal cell carcinoma.
Enache AO; Stepan AE; Mărgăritescu C; Pătraşcu V; Ciurea RN; Simionescu CE; Camen A
Rom J Morphol Embryol; 2018; 59(4):1115-1120. PubMed ID: 30845292
[TBL] [Abstract][Full Text] [Related]
34. Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery.
Hassanein AM; Proper SA; Depcik-Smith ND; Flowers FP
Dermatol Surg; 2005 Sep; 31(9 Pt 1):1101-6. PubMed ID: 16164857
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
36. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
37. CD34 and BerEP4 Are Helpful to Distinguish Basaloid Tricholemmoma From Basal Cell Carcinoma.
Turnbull N; Ghumra W; Mudaliar V; Vella J; Sanders DSA; Taibjee S; Carr R
Am J Dermatopathol; 2018 Aug; 40(8):561-566. PubMed ID: 29570129
[TBL] [Abstract][Full Text] [Related]
38. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
Yu L; Galan A; McNiff JM
J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
[TBL] [Abstract][Full Text] [Related]
39. Subtype-Specific Analyses Reveal Infiltrative Basal Cell Carcinomas Are Highly Interactive with their Environment.
Villani R; Murigneux V; Alexis J; Sim SL; Wagels M; Saunders N; Soyer HP; Parmentier L; Nikolaev S; Fink JL; Roy E; Khosrotehrani K
J Invest Dermatol; 2021 Oct; 141(10):2380-2390. PubMed ID: 33865912
[TBL] [Abstract][Full Text] [Related]
40. Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension.
Hendrix JD; Parlette HL
Arch Dermatol; 1996 Mar; 132(3):295-8. PubMed ID: 8607634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
